//Attributer script Skip to main content

Mobile Phlebotomy Academy/Foundations/Revenue models

Lesson 04

Understanding Mobile Phlebotomy Revenue Models

For owners comparing direct-pay, B2B, laboratory, institutional and research models. The question underneath all of them is the same: who is paying, for exactly what, and under what agreement?

  • 11 min read
  • Six revenue models
  • Reimbursement explained carefully

Lesson 4 of 30

Money path

Review Lesson 7 for pricing and Lesson 25 for financial management before choosing or expanding a revenue model.

Before you begin

This lesson explains the general framework. Verify the rules and requirements that apply to your state, employer, laboratory, payer, insurance arrangement and service model.

The six models

Mobile phlebotomy businesses can be paid in several different ways. The key question in every one of them is who is paying the business, for exactly what service, and under what agreement.

Direct-to-consumer

The patient pays the mobile service fee. Laboratory testing charges may be entirely separate, and the distinction needs to be clear to the patient before the visit.

Physician or practice-paid

A practice may pay per appointment, under a monthly service arrangement, or through another contracted model.

Laboratory contract

A laboratory may engage a mobile collection provider under defined operational and payment terms. Acceptance of a specimen does not itself mean the lab owes you payment.

Research and specialty testing

Protocol-specific collections may involve timed draws, kits, processing, shipping and documentation — all of which change the pricing.

Institutional, employer and senior living

Multiple patients at one location improve density and reduce travel cost per collection, which is why these accounts are worth pursuing.

Third-party reimbursement

The most misunderstood of the six, and the one that requires the most care before you rely on it.

Third-party reimbursement

Do not assume Medicare or commercial insurance automatically pays an independent mobile collection company. CMS does allow specific specimen-collection fees and travel allowances in defined circumstances, for eligible specimens, patients and billing arrangements.

CY2026 specimen-collection fees

For CY2026, CMS lists a general specimen-collection fee of $9.34, and $11.34 for specified skilled-nursing-facility and home-health-agency circumstances — both subject to eligibility restrictions.

These are CY2026 figures. Re-verify against current CMS rates before billing or before relying on them in any business plan. Amounts and eligibility rules change annually.

Comparing models

B2B work may pay considerably later than direct-pay work. Track days to payment and customer concentration — a single customer representing most of your revenue is a risk regardless of how good the relationship feels.

The comparison that matters

Compare models on contribution, not headline price.

Revenue minus labor, travel, supplies, processing and payment costs, and administrative burden. A lower-priced contract with high density can beat a premium direct-pay visit forty minutes away.

Common mistakes

The first is the one most likely to appear in marketing copy, and it is the one most likely to cause a problem.

  • Saying Medicare pays mobile phlebotomists as a blanket claim
  • Confusing mobile convenience fees with covered benefits
  • Ignoring accounts receivable
  • Taking a low-margin contract for the volume
  • Depending on one customer for most of the revenue

Where XpediPro fits

As revenue sources diversify, structured appointment, payment and referral-source data shows which customers, services and territories are actually creating the healthiest business — rather than which ones feel busiest.

See how XpediPro works

Action checklist

6 things to settle before moving on to Lesson 5.

0 of 6 complete

FAQs

Can I bill Medicare for home draws?

Only in specific eligible circumstances and through a compliant billing arrangement. Verify current CMS rules, your enrollment status and the actual service before assuming any of it applies to you.

Should I accept B2B contracts with a lower per-visit price?

Only if density, acquisition cost, payment timing and total contribution make the relationship attractive. Volume at a loss is still a loss.